# SMART Design to Compare Antipsychotic Treatments in Treatment-Resistant Schizophrenia

> **NCT04528095** · PHASE3 · UNKNOWN · sponsor: **Shanghai Mental Health Center** · enrollment: 162 (estimated)

## Conditions studied

- Treatment-resistant Schizophrenia

## Interventions

- **DRUG:** Clozapine
- **DEVICE:** MECT
- **DEVICE:** DBS

## Key facts

- **NCT ID:** NCT04528095
- **Lead sponsor:** Shanghai Mental Health Center
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-12
- **Primary completion:** 2022-12
- **Final completion:** 2022-12
- **Target enrollment:** 162 (ESTIMATED)
- **Last updated:** 2020-08-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04528095

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04528095, "SMART Design to Compare Antipsychotic Treatments in Treatment-Resistant Schizophrenia". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04528095. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*